Advancing the development of next-generation immunotherapies 


Life Sciences

Anzu Investment:

January 2020

Illuminating the immune landscape

ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution.

The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information.

This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.

Interested in more information?

Complete the form below to get connected directly with the portfolio company